方盛制药：子公司洛索洛芬钠凝胶贴膏获得药品注册证书

Core Viewpoint - Fangsheng Pharmaceutical's subsidiary, Guangdong Fangsheng Jianmeng Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the production of Loxoprofen Sodium Gel Patch, marking a significant milestone in the company's product portfolio [1] Group 1 - The drug registration certificate for Loxoprofen Sodium Gel Patch was issued on January 23, 2026, allowing for production [1] - A total of 15 companies in China have obtained drug registration certificates for Loxoprofen Sodium Gel Patch, indicating a competitive market landscape [1] - Among the registered companies, listed firms include Jiutian Pharmaceutical (300705), Darentang (600329), and China Resources Sanjiu (000999), while the remaining manufacturers are non-listed [1]